20 dogs in your waiting room with lumps and bumps - how do you spot the 3 with cancer? (LVS25)

20 Nov 2025 | 13:00 - 13:50 | Exhibitor Showcase Theatre 2

Dermal and subcutaneous tumours account for nearly a third of canine cases, yet fewer than 50% of masses are ever sampled, resulting in delayed diagnosis, postponed treatment, and a poorer prognosis. 

This diagnostic gap places patients at risk and leaves clinicians facing difficult decisions with limited evidence.

Using the “20 dogs in a waiting room” analogy, we will explore HT Vista’s five outcome categories- from low cancer risk to moderate- and high- cancer risk findings, and tumour-specific Lipoma and Mast Cell diagnostic alerts. Each provides clear, practical guidance on when to sample tissue and when it can be safely deferred, supporting confident decision-making, reassuring owners, and enabling earlier intervention.

Through case studies and panel discussion, we will demonstrate how HT Vista improves outcomes, saves lives, and supports practice growth- delivering the next generation of non-invasive AI-powered cancer detection technology.

• Explain the principles of Heat Diffusion Imaging and the innovations introduced with HT Vista.
• Explore the five HT Vista outcome categories and apply them to clinical decision-making.
• Assess case studies to understand how earlier intervention improves patient outcomes and client reassurance.
• Recognise the benefits of HT Vista for workflow efficiency and practice growth.

Speakers:
Liron Levy-Hirsch, BSc (Hons) DVM MRCVS, Managing Director UK - HTVET LTD, HT Vista Ltd
Asher Fink, C-Suite Executive, NYU MBA, Chief Commercial Officer - HT VET Ltd
Hannah West, Clinical Director - Maltman Cosham Veterinary Clinic
Sian Smith, Head Nurse - Maltman Cosham Veterinary Clinic
Anish Patel, BVetMed GPCert (Endo) MRCVS, Clinical Director And Practice Owner - Max and Min Veterinary Practice

Delivered by: